img

Global Marek's Disease Vaccine Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Marek's Disease Vaccine Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Marek's Disease Vaccine Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Marek's Disease Vaccine industry at home and abroad, estimate the overall market scale of the Marek's Disease Vaccine industry and the market share of major countries, Marek's Disease Vaccine industry, and study and judge the downstream market demand of Marek's Disease Vaccine through systematic research, Analyze the competition pattern of Marek's Disease Vaccine, so as to help solve the pain points of various stakeholders in Marek's Disease Vaccine industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Marek's Disease Vaccine Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Marek's Disease Vaccine Market?
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Major Type of Marek's Disease Vaccine Covered in XYZResearch report
Bivalent Vaccine
Monovalent Vaccine
Application Segments Covered in XYZResearch Market
Veterinary Pharmacy
Online Sale
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Marek's Disease Vaccine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Marek's Disease Vaccine Market by Value
2.2.1 Global Marek's Disease Vaccine Revenue by Type
2.2.2 Global Marek's Disease Vaccine Market by Value (%)
2.3 Global Marek's Disease Vaccine Market by Production
2.3.1 Global Marek's Disease Vaccine Production by Type
2.3.2 Global Marek's Disease Vaccine Market by Production (%)

3. The Major Driver of Marek's Disease Vaccine Industry
3.1 Historical & Forecast Global Marek's Disease Vaccine Demand
3.2 Largest Application for Marek's Disease Vaccine (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Marek's Disease Vaccine Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Marek's Disease Vaccine Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Marek's Disease Vaccine Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Marek's Disease Vaccine Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Marek's Disease Vaccine Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Marek's Disease Vaccine Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Marek's Disease Vaccine Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Marek's Disease Vaccine Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Marek's Disease Vaccine Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Marek's Disease Vaccine Average Price Trend
12.1 Market Price for Each Type of Marek's Disease Vaccine in US (2018-2022)
12.2 Market Price for Each Type of Marek's Disease Vaccine in Europe (2018-2022)
12.3 Market Price for Each Type of Marek's Disease Vaccine in China (2018-2022)
12.4 Market Price for Each Type of Marek's Disease Vaccine in Japan (2018-2022)
12.5 Market Price for Each Type of Marek's Disease Vaccine in India (2018-2022)
12.6 Market Price for Each Type of Marek's Disease Vaccine in Korea (2018-2022)
12.7 Market Price for Each Type of Marek's Disease Vaccine in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Marek's Disease Vaccine Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Marek's Disease Vaccine

14. Marek's Disease Vaccine Competitive Landscape
14.1 Merck
14.1.1 Merck Company Profiles
14.1.2 Merck Product Introduction
14.1.3 Merck Marek's Disease Vaccine Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Ceva
14.2.1 Ceva Company Profiles
14.2.2 Ceva Product Introduction
14.2.3 Ceva Marek's Disease Vaccine Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Zoetis
14.3.1 Zoetis Company Profiles
14.3.2 Zoetis Product Introduction
14.3.3 Zoetis Marek's Disease Vaccine Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Boehringer Ingelheim
14.4.1 Boehringer Ingelheim Company Profiles
14.4.2 Boehringer Ingelheim Product Introduction
14.4.3 Boehringer Ingelheim Marek's Disease Vaccine Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
14.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Company Profiles
14.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Product Introduction
14.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Merial
14.6.1 Merial Company Profiles
14.6.2 Merial Product Introduction
14.6.3 Merial Marek's Disease Vaccine Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Ruipu Biopharmaceutical Co., Ltd.
14.7.1 Ruipu Biopharmaceutical Co., Ltd. Company Profiles
14.7.2 Ruipu Biopharmaceutical Co., Ltd. Product Introduction
14.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
14.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Company Profiles
14.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Product Introduction
14.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Beijing Huadu Shihua Biological Products Co., Ltd.
14.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Company Profiles
14.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Product Introduction
14.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Guangxi Lichengdong Biological Co., Ltd.
14.10.1 Guangxi Lichengdong Biological Co., Ltd. Company Profiles
14.10.2 Guangxi Lichengdong Biological Co., Ltd. Product Introduction
14.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Marek's Disease Vaccine Industry (Volume)
Figure 2. Marek's Disease Vaccine Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Marek's Disease Vaccine Revenue in 2022
Figure 5. US Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Marek's Disease Vaccine Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Marek's Disease Vaccine Revenue, by Type (Million USD) (2018-2028)
Table 4. Marek's Disease Vaccine Production, by Type (K Unit) (2018-2028)
Table 5. Marek's Disease Vaccine Demand (K Unit) by Application (2018-2028)
Table 6. Marek's Disease Vaccine Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Marek's Disease Vaccine Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Marek's Disease Vaccine Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Marek's Disease Vaccine in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Merck Profiles
Table 61. Merck Marek's Disease Vaccine Product Introduction
Table 62. Merck Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Merck Strategic initiatives
Table 64. Ceva Profiles
Table 65. Ceva Marek's Disease Vaccine Product Introduction
Table 66. Ceva Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Ceva Strategic initiatives
Table 68. Zoetis Profiles
Table 69. Zoetis Marek's Disease Vaccine Product Introduction
Table 70. Zoetis Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Zoetis Strategic initiatives
Table 72. Boehringer Ingelheim Profiles
Table 73. Boehringer Ingelheim Marek's Disease Vaccine Product Introduction
Table 74. Boehringer Ingelheim Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Boehringer Ingelheim Strategic initiatives
Table 76. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Profiles
Table 77. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Introduction
Table 78. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Strategic initiatives
Table 80. Merial Profiles
Table 81. Merial Marek's Disease Vaccine Product Introduction
Table 82. Merial Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Merial Strategic initiatives
Table 84. Ruipu Biopharmaceutical Co., Ltd. Profiles
Table 85. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Introduction
Table 86. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Ruipu Biopharmaceutical Co., Ltd. Strategic initiatives
Table 88. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Profiles
Table 89. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Introduction
Table 90. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Strategic initiatives
Table 92. Beijing Huadu Shihua Biological Products Co., Ltd. Profiles
Table 93. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Introduction
Table 94. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Beijing Huadu Shihua Biological Products Co., Ltd. Strategic initiatives
Table 97. Guangxi Lichengdong Biological Co., Ltd. Profiles
Table 98. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Introduction
Table 99. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Guangxi Lichengdong Biological Co., Ltd. Strategic initiatives